Stockscreener 앱 받기
5.44
6.53%
-0.38
시간 외 거래:
5.30
-0.14
-2.57%
전일 마감가:
$5.82
열려 있는:
$5.8
하루 거래량:
337.55K
Relative Volume:
0.48
시가총액:
$32.04M
수익:
$14.58M
순이익/손실:
$-12.57M
주가수익비율:
-0.9577
EPS:
-5.68
순현금흐름:
$-13.07M
1주 성능:
-21.73%
1개월 성능:
+94.29%
6개월 성능:
-3.03%
1년 성능:
+122.04%
1일 변동 폭
$5.17
$5.80
1주일 범위
$5.17
$7.03
52주 변동 폭
$1.97
$7.95
비보스 테라퓨틱스 Stock (VVOS) Company Profile
명칭
Vivos Therapeutics Inc
전화
(866)908-4867
주소
7921 SOUTHPARK PLAZA,, LITTLETON
VVOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
5.44 | 40.93M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
비보스 테라퓨틱스 주식(VVOS)의 최신 뉴스
Vivos Therapeutics Inc. Stock Analysis and ForecastConsistently outstanding ROI - Autocar Professional
Is Vivos Therapeutics Inc. a good long term investmentRapid wealth multiplication - jammulinksnews.com
What analysts say about Vivos Therapeutics Inc. stockMarket-beating returns - jammulinksnews.com
What drives Vivos Therapeutics Inc. stock priceSuperior portfolio returns - jammulinksnews.com
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
Vivos Therapeutics Shares Skyrocket After Medicare Greenlights VidaSleep Oral Device - MSN
Vivos Therapeutics shares rise 1.81% premarket after NKGen Biotech's new funding announcement. - AInvest
What makes Vivos Therapeutics Inc. stock price move sharplyFree Predictions - Newser
Why Vivos Therapeutics Inc. stock attracts strong analyst attentionFree Predictions - Newser
How Vivos Therapeutics Inc. stock performs during market volatilityFree Stock Market Insider Analysis - Newser
CPAP Is Failing Patients With OCD--Vivos Exposes the Hidden Mental Health Risk - PRWeb
Reviewing Recursion Pharmaceuticals (NASDAQ:RXRX) & Vivos Therapeutics (NASDAQ:VVOS) - Defense World
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Stock Rockets 60% As Investors Are Less Pessimistic Than Expected - simplywall.st
Regulatory Approval Fuels Uptrend In Vivos Therapeutics (VVOS) Stock - statereviewer.com
Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance - SINA HONG KONG LIMITED
Vivos Therapeutics stock soars after Medicare approves VidaSleep oral appliance - Investing.com
Vivos sleep apnea device gains Medicare coverage approval - Investing.com
Vivos sleep apnea device gains Medicare coverage approval By Investing.com - Investing.com UK
Vivos Therapeutics (VVOS) Device Shows Promise for Pediatric Sle - GuruFocus
Vivos reports positive results for non-surgical sleep apnea treatment - Investing.com
Short Interest in Vivos Therapeutics, Inc. (NASDAQ:VVOS) Grows By 48.3% - Defense World
SP Manager LLC Intends to Engage with Vivos Therapeutics, Inc. - MarketScreener
Vivos Therapeutics, Inc: SCN Acquisition Closed; Key Step in Strategic Pivot - Smartkarma
Comparing Vivos (OTCMKTS:RDGL) & Anika Therapeutics (NASDAQ:ANIK) - Defense World
Vivos Therapeutics Acquires The Sleep Center of Nevada - TipRanks
Vivos Therapeutics (VVOS) Completes Acquisition of Nevada Sleep Center | VVOS Stock News - GuruFocus
Vivos acquires largest Nevada sleep center, secures $11 million funding By Investing.com - Investing.com South Africa
Vivos Therapeutics Finalizes Acquisition Of The Sleep Center Of Nevada - Nasdaq
Vivos acquires largest Nevada sleep center, secures $11 million funding - Investing.com
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada, Expanding OSA Diagnostic and Treatment Capabilities - Nasdaq
Vivos Takes Over 7-Location Sleep Center Empire, Transforms Business Model with $11M Backing - Stock Titan
Critical Contrast: QHSLab (OTCMKTS:USAQ) & Vivos Therapeutics (NASDAQ:VVOS) - Defense World
vivos therapeutics appoints baker tilly as new auditor following merger - Investing.com Australia
vivos therapeutics appoints baker tilly as new auditor following merger By Investing.com - Investing.com India
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Sees Large Drop in Short Interest - Defense World
Sleep Apnea Oral Appliances MarketGlobal Forecast to - GlobeNewswire
Vivos Therapeutics (NASDAQ:VVOS) Cut to Sell at Wall Street Zen - Defense World
Vivos Therapeutics (NASDAQ:VVOS) Stock Rating Lowered by Alliance Global Partners - Defense World
Sector Update: Health Care - marketscreener.com
Vivos Issues $1.1 Million Convertible Promissory Note - marketscreener.com
Vivos Therapeutics Secures $1.1M Convertible Note - TipRanks
Vivos Therapeutics (NASDAQ:VVOS) Cut to “Hold” at Alliance Global Partners - Defense World
Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 2025 - MSN
비보스 테라퓨틱스 (VVOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.17%
자본화:
|
볼륨(24시간):